A practical, multigram synthesis of the 2-(2-(4-alkoxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide (DPA) class of high affinity translocator protein (TSPO) ligands-Reference-Cited by-同舟云学术

A practical, multigram synthesis of the 2-(2-(4-alkoxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide (DPA) class of high affinity translocator protein (TSPO) ligands

Published:2012-07 Issue:29 Volume:53 Page:3780-3783
ISSN:0040-4039
Container-title:Tetrahedron Letters
language:en
Short-container-title:Tetrahedron Letters

Author:

Banister Samuel D.,Wilkinson Shane M.,Hanani Raphy,Reynolds Aaron J.,Hibbs David E.,Kassiou Michael

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Reference23 articles.

1. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function

2. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane.

3. Is there a mitochondrial signaling complex facilitating cholesterol import?

4. The Translocator Protein (18 kDa): Central Nervous System Disease and Drug Design

5. Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repair

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An automated radiosynthesis of [18F]DPA-714 on a commercially available radiosynthesizer, Elixys Flex/Chem;Applied Radiation and Isotopes;2022-02

2. Adventures in Translocation: Studies of the Translocator Protein (TSPO) 18 kDa;Australian Journal of Chemistry;2021

3. Synthesis and evaluation of novel potent TSPO PET ligands with 2-phenylpyrazolo[1,5-a]pyrimidin-3-yl acetamide;Bioorganic & Medicinal Chemistry;2019-09

4. Novel potential pyrazolopyrimidine based translocator protein ligands for the evaluation of neuroinflammation with PET;European Journal of Medicinal Chemistry;2018-11

5. Derivatives of the pyrazolo[1,5- a ]pyrimidine acetamide DPA-713 as translocator protein (TSPO) ligands and pro-apoptotic agents in human glioblastoma;European Journal of Pharmaceutical Sciences;2017-01